Of note, among the genes mutated in statin-treated tumours (Table S2), Clcc1 and Kdm1a are proposed as mutational drivers by the Pan-Cancer Analysis of Whole Genomes Consortium (https://dcc.icgc.org/releases/PCAWG/driver_mutations) (The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium et al., 2020). This evidence concerns the gene CLCC1 and cancer.